When India decided to prioritize 1st doses of COVISHIELD & space doses by 3 months, there was a lot of controversy. It was absolutely the right move. 1) more 1st doses = more lives saved 2) longer gap = better immune response 3) leverages hybrid immunity (infection+1 dose)
-
-
Full disclosure, initially I did think it was risky to deviate from trials. However, I found the NYT piece that you & Dr Mina co-authored very compelling. It changed my mind (along with modeling & data on immune responses w/ different intervals. Fwiw y’all were clearly right.
-
Now that it’s clear that first dose prioritization saves lives and leads to a better immune response, some in India have shifted goal posts to “that doesn’t matter, the govt. did it because of supply”. Yeah, no shit geniuses. It saved lives & also resulted in a superior response.
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.